SRI tackles the most challenging health problems, such as cancer, infectious diseases, and neurodegenerative disorders. We work in partnership with clients in academia, biotechnology and pharmaceutical companies, and foundations.
SRI is also a leading drug discovery contractor and preclinical development contractor for several government agencies, including the National Institutes of Health and the National Science Foundation. To improve and save lives, SRI researchers investigate disease mechanisms and develop new treatments.
Drug Discovery and Development
SRI Biosciences provides drug discovery and development capabilities to take drugs from ideas to the Investigational New Drug status (Idea to IND®). SRI's pipeline has produced several marketed drugs and advanced well over 100 drugs to clinical trials.
SRI's Health Sciences Section, part of SRI Biosciences, conducts basic research and contract R&D to advance programs in sleep, cognition, pain, addiction, aging, obesity, and neurodegenerative diseases such as Alzheimer's and Parkinson's. We also strive to determine the environmental, behavioral, and biological contributors to human health and illness.
Medical Device Development
SRI’s multidisciplinary engineering has led to advanced medical and surgical devices such as novel diagnostic and drug delivery tools and devices sized for pediatric use.
SRI researchers develop computational approaches to address challenges in systems biology, such as elucidating metabolic pathways in bacteria and humans. Findings are shared with the global research community.